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Director of Thesis: 
Diabetes mellitus, which affects 15. 7 million people worldwide and is the 
sixth leading cause of death by disease, causes pathological changes in heart tissue 
that affect cardiovascular function. Exercise appears to have a significant influence on 
the reduction of these affects. The purpose of this study was to determine if low 
intensity, progressive, aerobic exercise could alter body weight, heart weight, and 
cardiovascular function in diabetic rats. Twenty-four male Sprague-Dawley rats were 
divided in to four groups; Control Exercise (CE), Control Sedentary (CS), Diabetic 
Exercise (DE), and Diabetic Sedentary (DS). A type I diabetic state was induced by a 
single injection of 65 mg/kg of streptozotocin. After a five-day training period, the 
exercise treatment groups began a nine-week experimental protocol of increasing 
activity. The speed was increased I m/min/week .and the incline was increased IO per 
week (experimental range: 15 m/min and a 5° incline and increased to 24 m/min with 
a 14 ° incline). After · the training period the animals were anesthetized, 
electrocardiograms were recorded and heart rate, systolic and diastolic blood 
pressures were determined using the Digi-Med transducers and software evaluation 
procedures. The animals were sacrificed and blood samples, heart, and pancreases 
were removed from each subject. Body weight was significantly decreased in both 
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diabetic groups. Exercise increased body weight in the Diabetic Exercise rats (DE: 
279.5±21.4 g > DS: 216.8±49.1 g), but decreased body weight in the Control Exercise 
group (CE: 437.7±3.2 g < CS: 504.2±10.1 g). Heart weight was also significantly 
decreased in the sedentary and exercised diabetic groups in comparison to the 
respective Control Sedentary and Control Exercised animals (CE: 1.55±0.02 g, CS: 
1.56±0.03 g, DE: 1.13±0.07 g, DS: 1.01±0.07 g). The diabetic rats did not have a 
significantly different heart rate when compared to non-diabetic rats. Mean systolic 
and diastolic blood pressures in the diabetic rats were not significantly different from 
non-diabetic animals. These results indicate that diabetes mellitus decreases body 
weight and heart weight, but the cardiovascular functions of heart rate and blood 
pressure were not significantly affected. 
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Introduction 
Diabetes mellitus affects 15.7 million people in the United States, (5.9 percent 
of the population) and accounts for 200,000 deaths per year, making it the seventh 
leading cause of death in the United States. It is considered one of the most expensive 
diseases in United States, costing 98 billion dollars a year in treatment, research, and 
lost productivity. (American Diabetes Association, 2000) 
The Expert Committee on the Diagnosis and Classification of Diabetes 
Mellitus (ECDCDM, 1997) described the disease as a group of metabolic disorders 
that are characterized by hyperglycemia. This condition can range in pathology from 
an autoimmune destruction of the insulin secreting p cells of the islets of Langerhans 
in the pancreas to increased tissue resistance in the target tissue. (ECDCDM, 1997) 
Symptoms and signs of diabetes mellitus include hyperglycemia, polyuria, 
polyphagia, blurred vision, and weight Joss. Diabetes mellitus is associated with 
diseases in major organ systems of the body that include the eyes, kidneys, heart, 
nerves, and blood vessels. This may lead to a loss of vision, peripheral and central 
neuropathy, cardiovascular disease, hypertension, and atherosclerosis. (ECDCDM, 
1997) The Jong-term affects of diabetes mellitus include renal dysfunction due to 
nephropathy and risk of amputation due to peripheral neuropathy. Degeneration of 
autonomic nerves leads to sexual, gastrointestinal, urogenital, and cardiac 
dysfunctions. (ECDCDM, 1997) 
The pancreas, the most important organ associated with diabetes mellitus has 
both exocrine and endocrine functions. The endocrine cells of the pancreas produce 
hormones that are utilized by all the major cell types. The production of these 
hormones takes place in cells located in the islets of Langerhans. The islets of 
Langerhans have three distinctive cell types (Figure 1 ). The D cells produce 
somatostatin. Somatostatin is produced in a variety of tissues including the 
hypothalamus and cells lining the digestive tract. The function of pancreatic 
somatostatin is to inhibit digestion of nutrients and to decrease nutrient absorption. A 
second cell type is the alpha ( a:) cell, which is responsible for the production of 
glucagon. The main site of action for glucagon is the liver and glucagon is 
responsible for raising glucose levels in the body by regulating the conversion of 
glycogen to glucose. The thi.rd islet cell type is the beta(~) cell. These are the most 
abundant cells in the islets of Langerhans and in the rat are located in the center of the 
islets. (Figure 1) (Sherwood, 1997) 
® Glucagon 
0 Somatostatln 
0 Insulin 
Figure 1: Schematic diagram of the islets of Langerhans in the pancreas of the rat. 
(Norman and Litwack, 1997) 
2 
Insulin production has direct effects on carbohydrate, fat, and protein 
metabolism. It also lowers plasma fatty acid, glucose and amino acid concentrations 
by promoting the storage of these compounds (Sherwood, 1997). Insulin is heavily 
involved in a number of biological processes that include metabolism, growth, 
nutrient transportation, and is the only hormone that can directly lower blood glucose 
concentrations 01 estergaard, 1999). 
The insulin receptor is a dimeric tyrosine receptor in which the ~ subunit is 
phosphorylated when insulin binds. These events cause adapter proteins called the 
insulin receptor substrate (IRS) to become phosphorylated. These proteins function as 
docking proteins for molecules downstream in the signal transduction pathway 
. ' 
(Figure 2). There are four subtypes of the IRS proteins (IRS-I, IRS-2, IRS-3, and 
IRS-4), but only IRS-I and IRS-2 are involved in the biological action of insulin 
(Whitehead, et al, 2000). However, Hagaki, et al (1999) showed that IRS-2 is not 
needed for either insulin or exercise stimulated glucose transport. One of the 
molecules involved in the insulin pathway is phosphatidylinositol-3-kinase (PBK), 
which is the key signal transducer in GLUT-4 translocation (Chibalin, et al, 2000). 
GLUT-4 vesicles are translocated to the plasma membrane and the surfaces ofT-
tubules and by using facilitated diffusion brings glucose into the cell. Research 
suggests that there are two separate intracellular pools for GLUT-4, a insulin sensitive 
pool and a exercise sensitive pool (Douen, et al, 1990; Coderre, et al, 1995). 
Hexokinase phosphorylates glucose after it is transported into the cell by GLUT-4. 
The phosphorylated glucose is then sent to the major biological pathways, such as 
3 
oxidative glucose metabolism, or stored as glycogen (Vestergaard, 1999). Defects in 
the IRS-I/ PI3K signal transduction pathway, decreased GLUT-4, and decreased 
glucose transport are associated with type 2 diabetes mellitus (Chibalin, et al, 2000). 
Plasma membr:u10 
=--
! 
! 
l 
Glycogen TCA, 
Figure 2: Flow diagram of the biological action of insulin at the target tissue. 
(Vestergaard, 1999) 
The .two most prevalent types of diabetes mellitus are Type I and Type 2 . 
Type I diabetes mellitus was formerly known as insulin dependent or juvenile 
diabetes mellitus but was reclassified by the ECDCDM in 1997 because ofa growing 
prevalence of adult onset insulin dependent diabetes. TyPe 1 results from an 
autoimmune destruction of the insulin producing ~ cells of the islet of Langerhans in 
the pancreas. (Sherwood, 1997) This destruction is caused by release of~ cell 
antigens, which are processed by macrophages and presented by helper T-cells. The 
4 
helper T-cells cause a response that leads to apoptosis (Figure 3) of the~ cells 
(Mandrup-Poulsen, 1998). Type 2 diabetes mellitus occurs when the target tissues or 
the insulin receptor becomes insulin resistance, which may be through decreased 
receptor affinity of down regulation of the insulin receptor. (Sherwwod, 1997). 
There are major differences between individuals with type I and type 2 
diabetes mellitus. A type 1 diabetic is usually average or below average in weight, 
prone to ketosis, and produce little or no insulin. Type I diabetes mellitus is usually 
diagnosed before the age of eighteen and accounts for 10 to 20% of the diabetics 
worldwide. Type I diabetes can only be treated with regular injections of insulin. A 
type 2 diabetic on the other hand, is usually overweight and produces normal levels or 
in some cases over produces insulin. Insulin production in type 2 diabetics does start 
to decrease as the individual ages. (ECDCDM, 1997) Type 2 diabetes is the most 
common form of diabetes mellitus, accounting for 80 to 90% of all diabetics. Type 2 
diabetes mellitus is usually diagnosed in adults over the age of 45 and is usually 
controlled through their diet and exercise in younger individual, but insulin is usually 
need be older individuals. (Sherwood, 1997; ECDCDM, 1997). 
Diabetes mellitus has major effects on the body as a whole. Since the insulin 
receptor is expressed in most areas of the body and is important in fuel uptake and 
transport, any defect or deficiency in the insulin receptor could have detrimental 
effects on the individual. Insulin has marked affect on glucose transport, glycogen 
· synthesis, cell proliferation, and gene expression. (Figure 2, Vestergaard, 1999) 
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Initial Damage to P cells caused toxins, viruses, or antibodies 
+ 
Release of p cell antigens 
+ 
Macrophages take up antigens and 
present them on surface 
+ Activation of helper T-cells 
. + Cytokmes produced 
Mononuclear cells accumulate in islet cells 
and activate endothelial cells 
i INF-y,._ ______ _., Macrophages 
Interleukin- I and lNF-a produced 
'--------iNOS producfd in p cells 
NO synthesfs initiated 
• Accumulation of superoxide anions 
• Increased oxidative stress caused by superoxide anions 
• Apoptosis induced in P cells 
• • P cells destroyed 
Figure 3: Autoimmune destruction of P cell in the islets of Langerhans. (Mandrup-
Poulsen, 1998) 
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Decreases in protein synthesis in cardiac and skeletal muscle has been linked 
to decreases in insulin production and sensitivity, which are characteristic of type I 
diabetics. (Flaim, et al, 1980; Jefferson, 1980; Fluckey, et al, 1996). GLUT-4 
concentrations have been shown to increase in the brain (Yannucci, et al, 1998), but 
decrease in the heart (Osburn, et al, 1997). Hall, et al (1995) showed as much as a 
70% decrease in GLUT-4 and a 19% decrease in GLUT-I concentration in diabetic 
rats. 
The most common and widely researched complication of diabetes mellitus is 
cardiac dysfunction. The cause is due to major alterations in the composition and 
function _of the heart. The myocardium of the diabetic heart has less contractile ability 
due to a build up of the free collagen and glycosylated proteins of collagen 
(Woodiwiss, et al, 1996; Riva, et al, 1998). These glycosylated fibers are more rigid 
and decrease the contractility of the heart muscle (Woodiwiss et al, 1996). Other 
studies have shown a significant rise in normal collagen in the diabetic ventricular 
wall and in the myocardial septum (Riva, et al, 1998). The myocardium has 
decreased levels of ATP, oxidative phosphorylation, creatine kinase, and 
phosphocreatine (Mohkar, et al 1993; Mohkar et al, 1992). Diabetic heart tissue also 
shows increased levels of glycogen, triacylglycerol, and free fatty acids (Paulson et 
al, 1992; Shehadeh and Regan, 1996). 
Calcium utilization and transport in the cardiac and skeletal muscle is also 
compromised in diabetic animals. Decreases in calcium uptake, transport, and binding 
have previously been reported (Tsuchida and Watajima, 1997). There is a debate on 
7 
the effects of diabetes mellitus on sacroplasmic concentration of calcium in the left 
ventricle. Magyar, et al (1992) showed a 3-fold increase in calcium levels. Wang, et 
al, (1997) noted that intracellular calcium levels in the heart decreased significantly. 
The diabetic heart experiences longer action potentials, which are caused by an 
increased plateau phase and delayed repolarization of the papillary muscles (Sauviat 
and Feuvray, 1986). These increased action potentials have been reported in both the 
atriums and ventricles of the heart (Shigematsu, et al, 1994; Wang, et al, 1995). 
The electrocardiogram (ECG) can be used to suggest cardiac dysfunction and 
autonomic nerve dysfunction (McEwen and Sima, 1989). The ECG waveform 
represents one cycle of electrical activity in the heart (Figure 4). The ECG can be 
used to determine whether the heart is functioning properly or if automonic 
neuropathy is present and how the disease is progressing. A direct relationship has 
been established between cardiac autonomic neuropathy and the elongation of the QT 
interval (Kahn, et al, 1987). Lengthening of the QT interval has been associated with 
diabetes mellitus (Chambers, et al, 1990) and increases the risk of sudden death 
because of the links to ventricular arrhythmia. Alterations in function include 
elongation of the QT interval (Chambers, et al, 1990), decreased cardiac reserve 
(Deblieux, et al, 1993), and hypertension (Weidmann, et al, 1993). 
The RR interval is the time between two consecutive PQRST complexes 
(Figure 4). This interval is used to calculate heart rate or to monitor autonomic 
neuropathy. RR intervals are increased due to vagal denervation which is 
characteristic of diabetes mellitus (McEwen and Sima, 1989). These measurements 
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are a valuable index of autonomic involvement and a sensitive, noninvasive method 
to assess vagus nerve dysfunction. Abnormal autonomic nerve function is one of the 
most common complications of diabetes mellitus (McEwen and Sima, 1989). Vagal 
dysfunction is responsible for cardiovascular, respiratory, gastrointestinal, and genito-
urinary dysfunction. Scaramuzza, et al (1998) showed that RR interval was 
significantly decreased in adolescent type I diabetics. This study also showed that 
there the significant difference in RR interval after an 18-month follow up was still 
present. This result suggests that a decrease in cardiac function is present even in the 
early stages of type I diabetes mellitus. 
p 
R 
Q 
I s L QT 
Interval 
T 
RR 
Interval 
p 
Q 
R 
s 
Figure 4: Representation of an Electrocardiogram (ECG) 
Experimentally induced diabetes mellitus in animals is the best way to study 
the effects of the disease. Numerous studies have been done to show that diabetes 
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T 
mellitus affects all tissues of the body. The most common way to induce diabetes in 
rodents is through injections of streptozotocin. Streptozotocin is a member of a group 
of chemicals that are said to be diabetogenic (Figure 5). Therefore, it is one of the 
most common ways to experimentally induce diabetes mellitus even though it is a 
known carcinogen, causing tumors in the kidneys, lung, and liver (ARC, 1998). 
Streptozotocin is a nitrosourea compound produced by the fungus Streptomyces 
achomogenes. The action of streptozotocin was thought to be through the nitroso 
group damaging DNA directly. Takasu, et al in 1991 discovered that streptozotocin 
actually upregulated the production of hydrogen peroxide which lead to DNA 
fragmentation resulting in apoptosis in the ~ cells of the islets of Langerhans in the 
pancreas. Therefore, streptozotocin conforms to Okamoto's model, which states 
oxygen radicals cause DNA fragmentation, which leads to ~ cell destruction (Figure 
6). (Takasu, et al, 1991) 
0 
H01111 11110H 
O NO II / 
HO NH-C-N 
" CH3 
Figure 5: Chemical structure of streptozotocin (N-(Methyl nitrosocarbamoyl)-D-
glucosamine) (Sigma Chemical Co.) 
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Streptozotocin administration 
+ 
Accumulation of Streptozotocin in islet cells 
+ Hydrogen Peroxide 
+ 
DNA fragmentation in islet cell 
+ 
Apoptosis of the ~ cells in the islet 
Figure 6: Okamoto's Model for induction of experimental diabetes mellitus 
(Okamoto, 1985) 
After injection of streptozotocin, increases are seen in CD8 cells, 
macrophages, apoptotic cells, and IFN-yproduced by helper T-cells and cytotoxic T-
cells. This is the typical type I diabetic immune response in the ~ cells of the islets of 
Langerhans. The effectiveness of streptozotocin is dependent on animal size and · 
gender. Males are more susceptible than females are to its diabetogenic affects 
(Rodrigues and McNeill, 1987). 
Hypertension is one of the most common complications of diabetes mellitus 
affecting humans. Hypertension occurs twice as often in diabetics than in normal 
individuals (ADA, 2000). Experimental blood pressure analysis in animal models has 
given mixed results. Several factors may be involved in this conflict, which include 
length of the diabetic state, the severity of the disease, and the equipment used to 
analyze blood pressure readings. Several studies have shown decreases in both 
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systolic and diastolic blood pressures (Pfaffman, 1980; Somani, et al, 1979). Other 
reports have shown that experimentally induced diabetes mellitus causes hypertension 
in the test subjects (Woodiwiss, et al, 1996; Riva, et al, 1998). Other studies show no 
change in blood pressure in experimental animals (Susie, et al, 1990; Oliveira, et al, 
1999;Scaramuzza, et al, 1998). Susie, et al (1990) states that any decrease in blood 
pressure could be caused by vasodialation induced by streptozotocin. The 
experimental diabetic state has shown to have a marked decrease on heart rate, which 
could cause a decrease blood pressure (Davidoff and Rodgers, 1990; Pfaffinan, 1980; 
and Woodiwiss, et al, 1996; Oliveira, et al, 1999). 
The study of the effects that exercise have on the structure and function of the 
body has been extensively research. This area, referred to as Exercise Science, has 
grown so much that exercise has almost become a scientific discipline of its own 
(Baldwin, 2000). Research has focused on two main types of exercise. The first type 
is resistance exercise. This type of exercise is performed by the subject lifting weight, 
and is used mainly to study muscular changes and changes in protein synthesis 
(Farrell, et al, 1998; Farrell, et al, 1999a; Farrell, et al, 1999b; Fedele, et al, 2000). 
Diabetics showed a significant increase in protein synthesis after resistance exercise . 
(Farnell, et al, 1998; Farrell, et al, 1999b). Both of the latter studies showed that 
severe resistance exercise in individuals had no effects. Farrell, et al, (1999a), showed 
that chronic exercise can increase muscle mass in diabetic animals. Fedele, et al, 
(2000), showed that a severe diabetic state inhibits this increase in protein synthesis. 
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The second type of exercise is aerobic exercise, which consists of running or 
swimming. In normal individuals, exercise can produce a lower resting heart rate, and 
larger stroke volumes (Fuller and Nutter, 1981 ). Aerobic exercise can lower blood 
lactate concentrations, increase peripheral insulin sensitivity, and lower muscle 
glycogen utilization (Henriksson, 1992). Numerous studies have shown that aerobic 
exercise improves both cardiac performance and composition in the diabetic 
individual. Experimental models have shown that exercise improves systolic function, 
left ventricular diastolic chamber compliance by decreasing stiffness (W oodiwiss and 
Norton, 1995), and increases cardiac compliance (Woodiwiss and Norton, 1996). 
Deblieux et al (1993) showed that exercise increased cardiac output, but only at high 
preload volumes. 
Aerobic exercise improves glucose homeostasis (Horton, 1988; Tancrede, et 
al, 1982; and Tan, 1982) and decreases glycosylated collagens and collagen subtypes 
(Woodiwiss and Norton, 1996). This form of exercise also decreases plasma lipids 
(Paulson, et al, 1987 and Tan, et al, 1982) and decreases maximal oxygen 
consumption (Wegner, et al, 1987). Deaths by myocardial infarctions can be 
decreased by aerobic exercise training (Dompierre, et al, 1990; Nadeau, et al, 1988). 
It also increases ATP, phosphocreatine, and oxidative phosphorylation in the diabetic 
heart (Mokhar et al, 1993). Swim training improves reduced glucose metabolism by 
increasing contractility, energetics, and catecholamine responsiveness in the 
myocardium of diabetic rats. (Takeda, et al, 1988). Exercise also increases GLUT-4 
transporters in the plasma membrane (Douen, et al, 1990). Myocardial GLUT-4 
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concentrations are increased in diabetic rats after moderate intensity aerobic exercise 
(Hall, et al, 1995). 
Aerobic exercise has been shown to have beneficial affects on blood pressure 
and heart rate. Aerobic exercise has been shown to increase lowered resting heart 
rates commonly seen in experimental diabetic animals (Mohkar, et al, 1993; De 
Angelis, et al, 2000; Riggs, et al, 1992). It also decreases cardiac output and 
normalizes hypertension in rats that are spontaneously hypertensive (Veras-Silva, et 
al, 1997). De Angelis, et al (2000) showed that aerobic exercise attenuates 
hypotension caused by diabetes mellitus induced by streptozotocin. 
The effect of exercise is dependent on a variety of factors which include sex, 
age, type and intensity of the training, and severity of the diabetic state. Females 
show less myocardial improvement than males when given the same training 
regiment (Schaible, et al, 1981 ). Swim training in female rats lead to a higher 
increase in cardiac mass than running regiments produced (Schaible, et al, 1985). 
Myosin ATPase activity changed only when the subjects were undergoing intense 
exercise regiments (Baldwin, et al, I 977). 
Exercise training has shown to have normalizing effects on the diabetic 
condition. According to the University of Pennsylvania Alumni study, exercise is 
important in the maintenance and prevention of high-risk individual for type 2 
diabetes mellitus (Heimrich, et al, 1991). It has also been shown to decrease a 
diabetic risk of developing certain forms ofheart disease (Woodiwiss, et al, 1996). 
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For these reasons, exercise should be a critical part of the treatment and maintenance 
of both type 1 and type 2 diabetics. 
This study had three goals. The first goal was to evaluate the affect of diabetes 
mellitus on morphometric measurements such as body weight, heart weight, and a 
relative comparison of heart weight to body weight. The second goal was to evaluate 
the affect of diabetes mellitus on the cardiovascular functions of heart rate, systolic 
blood pressure, and diastolic blood pressure. The third goal was to evaluate the affect 
of a low intensity, progressive aerobic exercise regiment on those morphometric and 
cardiovascular parameters. 
15 
Materials and Methods 
Twenty-four male Sprague-Dawley rats (Harlan Sprague Dawley Inc.) were 
housed in the Lappin Hall Animal Care Facility beginning at the age of twenty-eight 
days. These animals were housed two per cage under a lighting regime of twelve hour 
of light and twelve hours of dark and fed Purina Lab chow and water ad libitum. The 
animals were divided into four treatment groups with six animals per group. The 
treatment groups were labeled Control Exercise (CE); Control Sedentary (CS); 
Diabetic Exercise (DE); and Diabetic Sedentary (DS). 
Induction of the Diabetes State 
A type 1 diabetic state was induced in the diabetic treatment groups on age 
day thirty-five. Streptozotocin (Sigma Chemical Co.) was dissolved in sodium citrate 
buffer at pH 4.5 to a concentration of 65 mg/kg. The streptozotocin was administered 
in the tail vein using a lee syringe with a 27-gauge needle according to the procedure 
ofMaygar, et al, 1992; Shigematsu, et al, 1994; Hall, et al, 1995; and Wang, et al, 
1995. 
Blood Glucose Determination 
On age day forty-two, blood was drawn from each animal in the two diabetic 
treatment groups by clipping the end of the tail and collecting the blood in a 1.5-ml 
microcentrifuge tube. The clotted blood was then centrifuged at 7,000 rpm (Fischer 
Scientific, Micro V) for twenty minutes and the serum was drawn off the blood with a 
1 cc disposable transfer pipette. The serum was used to perform a spectrophotometic 
analysis for blood glucose levels using the 510-A Glucose Determination Kit (Sigma 
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Diagnostics). Briefly, 25µ1 of serum was mixed with 0.5 ml of deionized water in a 
15 ml glass cuvette. A 500 mg/di glucose standard was made by mixing 25-µl of the 
glucose standard solution with 0.5-ml of deionized water in a 15-ml glass cuvette. 
The tubes were incubated at 37°C. for 30 minutes (Fisher Scientific, Isotemp 
Waterbath). Absorbancies were measured on a spectrophotometer (Fisher Scientific, 
Spectro-Master415) blanked with water at 450 nm. Blood glucose levels were 
calculated using the following calculations: 
Serum Glucose Concentration (mg/di)= Absorbance of the sample x 100 
Absorbance of the standard 
Blood Glucose Concentration (mmol/dl) = Serum glucose concentration (mg/di) 
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Any animal that had a blood glucose level of 20 mmol/ di or higher was 
considered diabetic and kept in the study (Sauviat and Feuvray, 1986; Shigematsu, et 
al, 1994). 
Aerobic Exercise Protocol 
On age day forty-two, the exercise treatment groups (DE and CE) were started 
on an exercise-preconditioning regime. This period lasted five-days and consisted of 
the animals running on a rodent treadmill (Columbus Scientific Instruments). The 
speed was increased from IO m/min to 15 m/min at a rate of 1 m/min/day. The incline 
of the treadmill was increased from 0° to 5° at a rate of 1 °/day. The animals were, 
encouraged to run using an electrical grid at the posterior end of the treadmill. 
On age day forty-nine, the exercise treatment groups started the exercise 
protocol, which consisted of exercise for fifteen minutes a day for five consecutive 
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days and two days of rest. The speed of the treadmill was increased from 15 m/min to 
24 m/min at a rate of 1 m/min/week. The incline of the treadmill was increased from 
5° to 14° at a rate of I 0 /week. The exercise protocol lasted for nine weeks. 
Anesthesia 
After the end of the nine-week aerobic exercise regiment, the animals were 
housed in a quiet room for twenty-four hours. The animals were placed in an 
anesthesia chamber for small animal anesthesia (ANESCO Inc.), which was then 
filled with I 00% 02 at 4 L/min for three minutes. Then the chamber was filled with 
isoflurane (Mallinckrodt Veterinary Inc.) at a final concentration of3 percent in 0 2 at 
a rate of 3 L/min. The rats were transferred to the surgical bench where the anesthetic 
plane was maintained using a small rodent nose cone secured to the animal. 
Blood Pressure Analysis Setup 
A cannula was formed from a 25 cm section of polyethylene tubing (PE-50) 
with one edge beveled with a pair of fine scissors. A 22-gauge needle was cut, 
leaving a non-crimped I-cm section extending from the hub of the needle. This was 
inserted into the non-beveled end of the tubing. The cannula was soaked overnight in 
I 00 units/ml heparinized saline. The transducer was prepared by connecting three-
way stopcock at each end and filled with 0.9% saline so that no air bubbles were 
evident. A three-way stopcock was placed on the hub end of the cannula, both were 
flushed with heparinized saline, and connected to the transducer. 
The Digi-Med Blood Pressure analyzer (Micro-Med Inc., Louisville, KY) was 
used to measure blood pressure in vivo. A mercury manometer was used to calibrate 
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the analyzer after it had been turned on and warmed up for a least fifteen minutes. 
The manometer was connected to the transducer and the pressure was raised to above 
100 mmHg. Then the Blood Pressure Analyzer was set to match the manometers 
reading. 
Isolation of the Carotid Artery 
After the animal was at the proper plane of anesthetization, the carotid artery 
was isolated using a mid-ventral cervical approach. A scalpel with a number 10 blade 
was used to open a two-inch incision through the skin of the neck over the trachea. 
With two pairs of pointed end forceps, the incision was pulled open, extending the 
incision to about one-inch wide in length. The same forceps were used to separate the 
fascia and overlaying muscle layers. Once the trachea was exposed, the area to the 
right of the trachea was dissected so that the right common carotid artery and vagus 
nerve were visible (Figure 7). A one-half inch section of the carotid artery and vagus 
nerve were dissected and isolated away from the rest of the tissue. Then, the artery 
was isolated away from the nerve. A small pair of forceps was placed under the 
carotid so that the artery was held above the opening. Three sutures were placed 
around the carotid artery as shown in Figure 8. The first suture was placed at the 
anterior-most end of the exposed carotid. This suture was secured and tied tight to 
prevent the back flow of blood from the head. The next suture was placed under the 
artery posteriorly, closest to the heart, but was not tied. The last piece of suture was 
placed between the two others and tied with one loop very loosely. The ends of the 
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posterior suture were grasped with a pair of small hemostats and the suture was pulled 
tight to occlude the flow of blood from the heart. A small hole was cut in the right 
common carotid artery with a pair of Vanna type vascular scissors. The beveled end 
of the cannula was inserted into the hole and pushed posterior toward the suture that 
was being used to stop the blood flow from the heart. The two remaining sutures were 
secured around the artery and tied to hold the cannula in place. After the cannula was 
secured, it was flushed with heparinized saline to prevent clot formation. 
Rt. C rotid-- -
Figure 7: Representation of the incision site and visualization of the carotid artery and 
vagus nerve. 
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Head 
Suture #1 
(Tie tight) 
Suture #3 
(Occluder) 
Figure 8: Representation of the carotid artery and the placement of the three sutures. 
Electrocardiograph Analysis 
While under anesthesia, the electrocardiograph (ECG) electrodes were 
connected to the animal in a Lead II setup. This consisted of the blue alligator clip 
(negative lead) being attached to a T-pin in the right front leg; the red alligator clip 
(positive lead) being attached to a T-pin in the left rear leg; and the white alligator 
clip (ground lead) being attached to a T-pin in the right rear leg. The ECG electrodes 
were connected to the Digi-Med Sinus Rhythm Analyzer (Micro-Med Inc., 
Louisville, KY), which was connected to a computer (Gateway Inc.). Using the Digi-
Med System Integrator 200-8 (DMSI) software (Micro-Med Inc, Version 1.7), the 
data were recorded every 0.5 seconds for about one-minute. The data were saved as a 
text file and a wave form file. Both were converted to an ASCII format using 
Waveform Converter (Micro-Med Inc.) and were examined using Microsoft Excel 
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(Microsoft Inc.). The waveform file was used to graph the ECG and the text file was 
used to calculate RR intervals and heart rates. 
Blood Pressure Analysis 
After the cannula was secured and flushed with heparinized saline, the 
transducer was connected to the Digi-Med Blood Pressure Analyzer (Micro-Med 
Inc.). The data were collected using the DMSI software every 0.5 seconds for about 
one-minute. The data were stored as text and wave form files. These files were 
converted to ASCII format and were examined with using Microsoft Excel, as 
described previously. 
Morphometric Analysis 
Before anesthetizing the animals, all individuals were weighed in grams on a 
rodent triple beam balance. After data collection, the animals were euthanized by 
decapitation using a rodent guillotine. Blood samples were taken from the animals 
and the hearts were removed. The blood samples were placed in micro-centrifuge 
tubes and blood glucose levels were determined using a colormetric assay (Sigma 
Diagnostics) as described previously. The hearts were weighed and frozen on dry ice 
and acetone. The pancreases from representative animals in each group were 
removed, fixed in I 0% formalin, and sent to St. Claire Medical Center in Morehead, 
KY. The samples were stained with hemotoxylin and eosin stain, sectioned at 10 µm, 
and mounted cin microscope slides for evaluation of the islets of Langerhans. 
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Statistical Analysis 
Statistical analysis was performed using Sigma Stat statistical package (Jandel 
Scientific Software Inc.). Descriptive statistics were performed for all treatment 
groups. Then, the mean for each studied parameter from each treatment was used to 
run a One Way Analysis of Variance (ANOVA). For any parameter found to be 
significant, pairwise comparisons were performed using a Student-Neuman-Kuels 
test. All significance was tested to the p<0.05 level. 
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Results: 
Blood Glucose Determination 
Blood samples were taken from the diabetic animals at age day 35 and at 
autopsy blood used to run a colormetic analysis for blood glucose concentration. 
Samples taken at 35 days of age, one week after the injection of streptozotocin 
showed that the all rats in the diabetic groups had serum glucose levels greater than 
20 mmol/dl and averaged 25.5 mmol/dl. The results of the serum glucose 
determination taken from the rats at autopsy are shown in Table I. Table I indicates 
that the mean blood glucose concentrations of the diabetic groups are above 20 mmol/ 
di and were significantly higher than those of the controls. 
Table I. Mean Blood glucose concentrations of all the treatment 
groups at time of autopsy. Values expressed as a mean ±SEM. A 
different superscript letter within columns represents significance 
atp<0.05. 
Treatment Group 
Control Exercise 
Control Sedentary 
Diabetic Exercise 
Diabetic Sedentary 
Microscopic Evaluation 
Mean Blood Glucose 
Concentration (mmol/ di) 
15.3 ± 1.0• 
12.3 ± 2.2· 
23.6 ± 0.7b 
23.7 ± 0.5b 
In Figure 9, two islets are present in each I 00X microscopic field. This is 
typical for a normal rat pancreas section. This is in direct contrast to the diabetic 
animals which have veryfow islets. The islets of Langerhans of the non-diabetic rat at 
400X magnification are sho~n in Figure I 0. A single measurement with an ocular 
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micrometer indicates that this islet had an area of 140 µm 2, and contained a large cell 
population with many light staining cell present that had large nuclei. These lighter 
staining cells are the insulin producing~ cells of the islets of Langerhans. In contrast, 
Figure 11 shows the Islets of Langerhans for the diabetic rats, whjch have a greatly 
reduced number of these cells. The size of the Islet is dramatically smaller wi th an 
area of 35 µm 2. 
Figure 9: Islet of Langerhans of a non-diabetic rat stained with H&E, I 00X total 
magnification 
25 
Figure I 0: Islets of Langerhans of a non-diabetic rat stained with H&E, 400X total 
magnification. 
Figure I I: Islet of Langerhans of a diabetic rat stained with H&E, 400X total 
magnification. 
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Morphological Data: 
Morphological data are presented in Table 2. Absolute body weight decreased 
significantly in both of the diabetic groups when compared to the control group. 
Exercise caused a significant increase in the absolute body weight in the diabetic 
animals and a significant decrease in the control animals. These results are seen 
graphically in Figure 12. Absolute heart weight is also significantly decreased in the 
diabetic animals. Exercise had a non-significant effect on heart weight in the diabetic 
heart (Table 2, Figure 13). Relative heart weights for the diabetic animal significantly 
increased compared to the control animals. (Table 2, Figure 14). 
Table 2. Absolute body weight, absolute heart weight, and relative heart weight. All 
data are expressed as the mean± SEM. A different superscript letter within columns 
denotes significance at the p<0.05 
Treatment Grou s Body Wei ht ( Heart Wei t Relative Heart Wei ht ( 
Control Exercise 437.7±2.9. 1.55±0.023• 3.55±0. 63" 
Control Sedentary 504.2±8.9b 1.56±0.034" 3.11±0.12• 
Diabetic Exercise 279.5±21.4° J.13±0.067b 4.08±0.22b 
Diabetic Sedenta 2 J 6.8±20. J d l.0!±0.067b 4.72±1.35 b 
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Figure 12: Absolute body weight for the four treatment groups. All data are 
expressed, as mean ± SEM. Groups with a different letter above the bars are 
significant at p <0.05. 
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Figure 13: Absolute heart weight for all the treatment groups. AU the data are 
expressed as mean ± SEM. Groups with a different letter above the bars are 
significant at p<0.05 
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Figure 14: Relative heart weight for all the treatment groups. All data are expressed 
as mean ± SEM. Groups with a different letter above the bars are significant at 
p<0.05. 
Electrocardiograph Analysis: 
RR intervals were measured from the electrocardiographs and an average RR 
interval was calculated. There is no significant difference between the control groups 
and the diabetic animals. There is also no significant difference in the exercise 
animals compared to the sedentary groups (Figure 15). Average RR interval was used 
to calculate mean resting heart rate. There is no significant difference between any of 
the treatment groups in mean resting heart rate. (Figure 16) 
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Figure 15: RR intervals for all the treatment groups. All data are expressed as a mean 
± SEM. Groups with a different letter above the bars are significant at p<0.05. 
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Figure 16: Mean heart rate for all the treatment groups. All data is expressed as the 
mean ± SEM. Groups with a different superscript letter above the bars are significant 
atp<0.05. 
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Blood Pressure Analysis: 
Mean systolic blood pressures were not significant when the diabetic animals 
are compared to both respective control groups. (Figure 17). Mean diastolic blood 
pressure was significantly decreased in the diabetic exercise group compared to the 
control exercise treatment group. (Figure 18). 
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Figure 17: Mean systolic blood pressure for all treatment groups. All data expressed 
as the mean± SEM. Groups with a different letter above the bars are significant at 
p<0.05. 
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Figure 18 Mean diastolic blood pressure for all treatment groups. All data are 
expressed at the mean± SEM. Groups with a different letter above the bars are 
significant at p<0.05. 
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Discussion 
This study was performed to determine if exercise has an influence on the 
streptozotocin induced diabetic condition. Morphometric comparisons of body 
weight, heart weight, and relative heart weight (body/ heart weight) were included in 
this study. The cardiovascular parameters of electrocardiograms, heart rate, and 
systolic and diastolic blood pressures were also evaluated. Streptozotocin induced 
diabetes has been used in a number of experimental diabetic studies, and the rat 
model produced from streptozotocin injection is the most widely used model to study 
Type I diabetes mellitus in humans. Streptozotocin-induced diabetes is also an 
excellent model for studying the alteration the heart goes through during the 
progression of the disease. Figures 10 and 11 provide histological evidence of the 
establishment of the diabetic state. This is evident by a decrease in area of the islet of 
Langerhans and by the decrease in the lighter staining insulin-producing ~ cells. 
Table I also shows that all the rats injected with streptozotocin had blood glucose 
concentrations above 20-mmol/ di, which has been shown by other studies to 
experimentally represent the diabetic condition (Sauviat and Feuvray, 1986; 
Shigematsu, et al, 1994). The greater blood glucose concentration is a direct result of 
decreased insulin production caused by the streptozotocin induced damage of the ~ 
cells in the pancreas. This also indicates that a single injection of streptozotocin at a 
concentration of 65-mg/ kg is sufficient to induce diabetes in the murine model. 
Numerous studies have shown that both aerobic and resistance exercise have a 
beneficial effect on the diabetic state. Different exercise regiments have been shown 
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to increase contractile function of the heart (Osburn et al, 1997), decrease plasma 
lipids (Paulson, et al, 1987; Tan, et al, 1982) and improved contractile function 
(Woodiwiss and Norton, 1996). Exercise did not produce a decrease in blood glucose 
concentration in the diabetic animals (Table I). Previous reports have shown 
conflicting results in regards to blood glucose concentrations. Dall'agilo, et al (1983) 
and Tancrede, et al ( 1982) showed significant decreases in blood glucose 
concentration in diabetics that were on a exercise training regiment. 
A decrease in body weight in diabetic animals has been shown in previous 
studies (Mohkar, et al, 1996; Susie, et al, 1990; Oliveira, et al, 1999). Table 2 and 
Figure 12 illustrates that there is a significant reduction in weight in both of the 
diabetic treatment groups when compared to the control groups. Exercise did increase 
body weight in the diabetic animals and decrease body weight in the control animals. 
The decrease in body weight of the control group could be a trained effect for loss of 
body fat. The exercise protocol was comparatively mild and may have not been 
sufficient to increase skeletal muscle mass, causing an overall decrease in body 
weight. The increase in body weight of the diabetics who were exercised could be due 
to increased insulin sensitivity in tissue. (Dall' agilo, et al 1983; and Tancrede, et al 
1982) This increased insulin sensitivity coupled with increased protein synthesis seen 
with certain forms of exercise (Farrell, et al, 1999a; Farrell, et al, 1999b) could result 
in increased muscle mass and body weight. The decrease in body weight in diabetic 
rats is accompanied by a significant decrease in heart weight (Table 2 and Figure 13). 
Exercise did not produce an increase in the heart weights of diabetic groups, a trend 
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seen in other studies. (Fuller and Nutter, 1981; Susie, et al, 1990). Table 2 and figure 
14 also shows that relative body weight ( also called cardiac weight index in research) 
significantly increased in the diabetic animals when compared to the control animals. 
This was also seen by Oliveira, el al (1999), who suggested that this was due to the 
loss of body weight rather than changes in heart morphology. 
The present study support the conclusions of Susie, et al (1990) and Oliveira, 
et al ( 1999) that the diabetic state causes no significant changes in blood pressure. 
Figures 17 and 18 indicate that there was no significant change in systolic and 
diastolic blood pressure in the diabetic groups when compared the control groups. 
However, these results were contrary to what was expected as most studies show that 
streptozotocin induced diabetes mellitus causes hypotension in rats (Woodiwiss, et al, 
1996; Davidoff and Rodgers, 1990). Woodiwiss, et al (1996) noted that diabetes 
cause a decrease in blood pressure that was normalized by exercise. This 
normalization in blood pressure could be due to a decrease in glycosylated collagens 
in the myocardium of the heart, which causes an increase in cardiac muscle 
compliance. Other studies show that decreases in adrenergic stimulation and in 
thyroid function could explain a decrease in blood pressure (Davidoff and Rodgers, 
1990). The significant weight loss could also explain a decrease in blood pressure 
(Susie, et al, 1990). 
RR interval was used to calculate heart rate and an increased RR interval 
represents a decrease in heart rate. Eventhough a decrease in RR interval is 
commonly seen, it was not apparent in this study (Figure 15). This decrease 
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represents an increase in abnormal autonomic nerve function (McEwen and Sima, 
1989). This study showed a no significant change in heart rate (Figure 16) which is 
in direct contrast to Fuller and Nutter, 1981; Wegner, et al 1987; and Susie et al, 
1990. All of these studies showed that diabetes caused a significant decrease in heart 
rate. This decrease has been associated with a decrease in adrenergic stimulation 
(Davidoff and Rodgers, 1990), hyperglycemia, insulinopenia, and myocardial 
stiffness. (Pfaffinan, 1980; Woodiwiss, et al, 1996) Aerobic exercise training is 
known to cause bradycardia with increased cardiac output. (Fuller and Nutter, 1981) 
The exercise intensity, duration, and the severity of the diabetic state and the 
low number of rats per experimental group could explain why these data conflicts 
with the published data. Other factors could have added to experimental error. The 
ECG and blood pressure analyses were performed while the animals were under gas 
anesthesia. There has been a shift in thinking in the way that anesthetic procedures 
are being used during these types of experiments. The shift is away from gas 
anesthesia (Isoflurane) to injectable anesthesia, such as sodium pentabarbitol. 
(Oliveira, et al, 1999) The reason for the switch is that injectable anesthesia are 
easier to control anesthetic plane than with a gas anesthesia. 
Another factor is the equipment used to collect the data. The blood pressure 
analyzer (BPA) is connected to a transducer that is then connected to the animal 
through the cannula. If the setup has any air left after filling with saline, the bubble 
will absorb the pressure and cause false blood pressure readings. The sinus rhythm 
analyzer SRA has a set of wire electrodes that have alligator clips at the end. This 
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setup is prone to picking up background noise and losing contact with the subject. 
Both of which will cause the reading to be false. The largest contribution to 
experimental error was that during the surgery portion of this study, four animals died 
before ECG and BP A measurements were taken. 
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Conclusions 
The specific aims of this study were to determine if streptozotocin induced 
diabetes mellitus produced any changes in morphology and cardiovascular parameters 
in rats and to assess if exercise could normalize these changes. This study provides 
evidence that streptozotocin-induced diabetes mellitus produces a decrease in body 
weight and that exercise can cause the body weight to normalize in streptozotocin-
induced diabetics. Diabetes mellitus did produce a reduction in heart weight that was 
not normalized by exercise. No significant changes were seen in RR interval, heart 
rate, systolic blood pressure, and diastolic blood pressure between streptozotocin-
induced diabetic rats that exercised and rats that did not. This indicates that 
streptozotocin-induced diabetes mellitus and exercise has no effect on these 
cardiovascular parameters. 
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